BridgeMD
New treatment option for Ischemic Stroke
Official title Atrial Fibrillation Screening Post Ischemic Cerebrovascular Events
ClinicalTrials.gov ID: NCT05134454
What this study is testing
- What it's testing
- Stroke is one of the leading causes behind death and permanent disability in adults. Atrial fibrillation (AF) is the most common clinical arrhythmia and its prevalence is steeply increasing with age.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 70 and older
You may be able to join if
- Patients aged ≥ 70 years
- A diagnosis of ischemic stroke or TIA within 14 days from inclusion.
You likely can't join if
- Previously diagnosed atrial fibrillation
- Contraindication to oral anticoagulant treatment according to Summary of Product Characteristics.
- Indication for anticoagulant treatment other than atrial fibrillation, e.g. venous thromboembolism or mechanical heart valve prosthesis
- Dual antiplatelet therapy not interchangeable to oral anticoagulation
- Patients with pacemaker, implantable cardioverter defibrillator or implantable cardiac monitor.
- Patients who, according to the investigator, will not be able to comply with the study protocol.
The study team makes the final eligibility decision.
Where it's taking place
- Stockholm, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 70 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockholm, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.